Achilles drops cell therapy program, braces for layoffs
网页4 天之前 · Achilles ended last year with 204 full-time employees plus 11 part-time staffers. A workforce reduction and other cost-cutting measures are in the works, but the details are still taking shape as ...
Achilles Therapeutics Announces Strategic Update
网页5 天之前 · Achilles Therapeutics Announces Strategic Update. –Achilles to discontinue development of TIL-based cNeT therapy–. –Cash position of $95.1 million as of June 30, 2024–. –BofA Securities engaged to provide strategic financial advice–. LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc …
Achilles stock climbs on strategic focus (NASDAQ:ACHL)
网页4 天之前 · Achilles climbs after decision to find strategic alternatives Sep. 19, 2024 8:19 AM ET Achilles Therapeutics plc (ACHL) Stock By: Dulan Lokuwithana , SA News Editor Play ( 1min )
Achilles Therapeutics to Lay Off Staff as Part of Review, …
网页5 天之前 · As of June 30, Achilles Therapeutics said it had $95.1 million in cash and cash equivalents. The company also said it has discontinued its TIL-based cNeT program and closed the phase 1/2a Chiron ...
Achilles Therapeutics Shares Are Trading Higher: What You
网页5 天之前 · Achilles Therapeutics is discontinuing its TIL-based cNeT program and closing its Phase I/IIa CHIRON and THETIS clinical trials The company's stock surged 31.7% in response to this announcement ...
Achilles Therapeutics plc (ACHL) Stock Price, News, Quote
网页0.8400. +1.11%. BOLT Bolt Biotherapeutics, Inc. 0.6280. -0.98%. Find the latest Achilles Therapeutics plc (ACHL) stock quote, history, news and other vital information to help you with your stock ...
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 ...
网页LONDON, April 04, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal ...
Achilles Therapeutics plc (ACHL) Stock Price, Quote & News
网页2024年9月10日 · Achilles Therapeutics: The First Full Position In My Tax Loss Selling Basket. ACHL has about $4.40 of cash per share on hand, yet it trades below $1. I believe that recent selling is due to tax loss sellers needing to recognize capital loss before the end of the year, and hence... 1 year ago - Seeking Alpha.
Achilles Therapeutics Announces Publication of Nature Cancer …
网页2023年12月18日 · Achilles is a clinical-stage biopharmaceutical company developing AI-Powered precision T cell therapies targeting clonal neoantigens: protein markers unique to the individual that are expressed on the surface of every cancer cell. The Company has two ongoing Phase I/IIa trials, the CHIRON trial in patients with advanced non-small cell lung ...
Achilles Therapeutics Provides Interim Phase I/IIa Update
网页2024年4月4日 · Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning ...